Morris Baumgarten, MD
Orthopedic Surgery · Duarte
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 47 years
- University of Southern California Keck School of Medicine, 1979
Offices
1 location
Hospitals listed: USC Arcadia Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baumgarten’s office at (626) 357-9931 to ask if they take your plan before you enroll.
California Medical Board record
Licence G43156 · Current
Licensed to practise in California · since 1980 · expires 2028-02-29 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Meridian Surgical Partners-California, LLC 20-4692585Brentwood, TN2.2% owner since 2013 · accredited by AAAHCInitial Accreditation1 inspection · last 2012-12-12
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- USC Arcadia HospitalArcadia, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Southern California, which runs 4 hospitalsPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.545, Oct 2024 – Sep 2025
See every measure and the patient survey for USC Arcadia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.545 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.76) · 1,417 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.27 (0.97 to 1.58) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.26 (152.13 to 228.39) · 89 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 413 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 432 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,815 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,579 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 6,907 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.52 (1.51 to 5.53) · 1,534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.88 (0.26 to 3.51) · 534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.97 to 3.94) · 1,486 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.28 (8.51 to 22.05) · 562 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.95 (4.26 to 11.64) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.81 to 3.77) · 479 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.11 to 1.29) · 5,994 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.9 · 285 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.652 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.694 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.145 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 196 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.9 · 487 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.1 · 723 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 863 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.4 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 155 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.5 to 16.9) · 408 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 538 cases | No different | Jan 2024 – Dec 2024 |
What patients said (560 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 34% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$117,674
Medicare paid this office $117,674 for 290 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 172 | $24,282 | $65 |
| Replacement of knee joint, both sides of knee | 16 | $13,007 | $765 |
| Return visit (30+ min) | 94 | $9,092 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $4,396 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,306 | $58 |
See all 15 services
| Short return visit (20+ min) | 172 | $24,282 | $65 |
| Replacement of knee joint, both sides of knee | 16 | $13,007 | $765 |
| Return visit (30+ min) | 94 | $9,092 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $4,396 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,306 | $58 |
| New patient visit (30+ min) | 58 | $3,663 | $63 |
| Injection into tendon or ligament | 55 | $3,360 | $40 |
| Long return visit (40+ min) | 18 | $2,050 | $114 |
| New patient visit (45+ min) | 18 | $1,745 | $97 |
| X-ray of knee, 3 views | 30 | $1,198 | $29 |
| X-ray of hip, 2-3 views | 15 | $750 | $38 |
| X-ray of foot, minimum of 3 views | 17 | $650 | $24 |
| Aspiration and/or injection of fluid from large joint | 11 | $639 | $46 |
| X-ray of knee, 1-2 views | 20 | $595 | $23 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 61 | $488 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 86 | More than 91% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of tissue | 21 | More than 70% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection into tendon or ligament | 80 | 75 | 59 | 63 | 79 | 85 |
| Replacement of knee joint, both sides of knee | 16 | 14 | 18 | 18 | 21 | 17 |
| Aspiration and/or injection of fluid from large joint | – | 17 | – | 17 | 13 | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
290 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 16% · Women 67% · Also on Medicaid 26% · Health risk score 1.53. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 45% · Chronic kidney disease 30% · Coronary heart disease 28% · Depression 26% · Heart failure 19% · COPD 19% · Atrial fibrillation 19% · Cancer 11% · Dementia 9% · Stroke 9%.
The office billed $381,775, Medicare allowed $162,337 and paid $117,674; for 1,636 services of 82 kinds; $3,209 of it was for drugs given in the office and $114,465 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 290 | 1,636 | 75 | 1.53 | $381,775 | $117,674 |
| 2023 | 277 | 1,712 | 75 | 1.49 | $411,617 | $125,525 |
| 2022 | 264 | 1,698 | 76 | 1.39 | $368,997 | $131,926 |
| 2021 | 254 | 1,195 | 74 | 1.42 | $303,055 | $106,602 |
| 2020 | 233 | 1,683 | 74 | 1.40 | $317,695 | $105,813 |
| 2019 | 280 | 1,687 | 75 | 1.39 | $342,385 | $110,273 |
| 2018 | 338 | 2,006 | 74 | 1.41 | $471,217 | $152,413 |
| 2017 | 323 | 1,806 | 73 | 1.44 | $366,820 | $122,873 |
| 2016 | 316 | 1,834 | 73 | 1.36 | $435,385 | $142,601 |
| 2015 | 312 | 2,029 | 73 | 1.62 | $395,121 | $137,810 |
| 2014 | 378 | 2,817 | 73 | 1.43 | $463,067 | $168,652 |
| 2013 | 401 | 2,885 | 74 | 1.51 | $482,394 | $163,894 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Short return visit (20+ min) | 146 | $22,183 | $70 |
| Replacement of knee joint, both sides of knee | 20 | $15,534 | $740 |
| Return visit (30+ min) | 91 | $10,923 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $5,550 | $129 |
| New patient visit (30+ min) | 62 | $5,112 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $4,972 | $66 |
| Injection into tendon or ligament | 59 | $3,486 | $44 |
| Long return visit (40+ min) | 16 | $1,876 | $117 |
| X-ray of knee, 3 views | 37 | $1,577 | $30 |
| New patient visit (45+ min) | 12 | $1,430 | $119 |
| X-ray of knee, 1-2 views | 25 | $865 | $27 |
| Aspiration and/or injection of fluid from large joint | 12 | $676 | $52 |
| X-ray of foot, minimum of 3 views | 18 | $536 | $22 |
| X-ray of hip, 2-3 views | 12 | $520 | $35 |
| X-ray of both hips, 2 views | 11 | $418 | $38 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 62 | $404 | None |
| X-ray of shoulder, minimum of 2 views | 12 | $350 | $29 |
2022: 17 services
| Short return visit (20+ min) | 163 | $28,585 | $73 |
| Replacement of knee joint, both sides of knee | 16 | $14,939 | $830 |
| Return visit (30+ min) | 73 | $7,313 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,932 | $156 |
| New patient visit (30+ min) | 64 | $4,951 | $77 |
| Injection into tendon or ligament | 45 | $2,864 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,632 | $60 |
| New patient visit (45+ min) | 13 | $1,597 | $123 |
| X-ray of knee, 1-2 views | 36 | $1,513 | $28 |
| X-ray of hip, 2-3 views | 11 | $1,011 | $40 |
| Aspiration and/or injection of fluid from large joint | 13 | $976 | $57 |
| X-ray of foot, minimum of 3 views | 23 | $974 | $30 |
| X-ray of knee, 3 views | 18 | $649 | $29 |
| X-ray of both hips, 2 views | 14 | $538 | $38 |
| X-ray of lower and sacral spine, 2-3 views | 14 | $481 | $34 |
| X-ray of shoulder, minimum of 2 views | 12 | $428 | $29 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 46 | $324 | None |
2021: 16 services
| Short return visit (20+ min) | 133 | $18,620 | $73 |
| Replacement of knee joint, both sides of knee | 15 | $18,316 | $1,018 |
| Return visit (30+ min) | 83 | $8,392 | $93 |
| New patient visit (30+ min) | 56 | $4,903 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,108 | $164 |
| Injection into tendon or ligament | 44 | $2,444 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,151 | $61 |
| X-ray of knee, 1-2 views | 33 | $1,661 | $30 |
| X-ray of foot, minimum of 3 views | 21 | $1,151 | $31 |
| X-ray of ankle, minimum of 3 views | 16 | $831 | $32 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $690 | $33 |
| X-ray of hip, 2-3 views | 13 | $654 | $36 |
| X-ray of knee, 3 views | 12 | $444 | $34 |
| X-ray of shoulder, minimum of 2 views | 12 | $383 | $27 |
| X-ray of pelvis, 1-2 views | 11 | $347 | $25 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 45 | $298 | None |
2020: 14 services
| Short return visit (20+ min) | 146 | $15,848 | $55 |
| Replacement of knee joint, both sides of knee | 13 | $14,674 | $1,048 |
| Return visit (30+ min) | 48 | $4,362 | $77 |
| New patient visit (30+ min) | 50 | $4,253 | $85 |
| Injection into tendon or ligament | 47 | $2,933 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,898 | $116 |
| X-ray of knee, 1-2 views | 31 | $1,139 | $25 |
| X-ray of hip, 2-3 views | 15 | $1,086 | $39 |
| Aspiration and/or injection of fluid from large joint | 12 | $829 | $49 |
| X-ray of foot, minimum of 3 views | 17 | $741 | $27 |
| X-ray of knee, 3 views | 16 | $612 | $27 |
| Short return visit | 11 | $447 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 47 | $370 | None |
| X-ray of pelvis, 1-2 views | 11 | $235 | $21 |
2019: 15 services
| Short return visit (20+ min) | 195 | $21,292 | $54 |
| Replacement of knee joint, both sides of knee | 15 | $15,955 | $997 |
| Return visit (30+ min) | 64 | $5,319 | $78 |
| Injection into tendon or ligament | 58 | $3,273 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,003 | $107 |
| New patient visit (30+ min) | 42 | $2,756 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,975 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,598 | $59 |
| X-ray of foot, minimum of 3 views | 30 | $1,307 | $24 |
| X-ray of knee, 1-2 views | 28 | $1,129 | $28 |
| X-ray of knee, 3 views | 33 | $1,127 | $26 |
| X-ray of hip, 2-3 views | 13 | $639 | $35 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 57 | $405 | None |
| X-ray of both hips, 2 views | 11 | $368 | $33 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $350 | $29 |
2018: 20 services
| Replacement of knee joint, both sides of knee | 22 | $29,227 | $1,271 |
| Short return visit (20+ min) | 203 | $22,391 | $53 |
| Return visit (30+ min) | 104 | $8,779 | $74 |
| New patient visit (30+ min) | 97 | $7,421 | $77 |
| Injection into tendon or ligament | 67 | $3,688 | $37 |
| Incision or partial removal of foot bone (other than big toe) to straighten toe | 12 | $3,058 | $170 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,840 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,020 | $112 |
| New patient visit (45+ min) | 17 | $1,828 | $108 |
| X-ray of knee, 3 views | 54 | $1,818 | $26 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,646 | $61 |
| X-ray of foot, minimum of 3 views | 39 | $1,632 | $23 |
| X-ray of knee, 1-2 views | 37 | $1,101 | $27 |
| X-ray of hip, 2-3 views | 15 | $684 | $34 |
| X-ray of shoulder, minimum of 2 views | 20 | $551 | $24 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 69 | $524 | None |
| X-ray of lower and sacral spine, 2-3 views | 16 | $449 | $28 |
| X-ray of ankle, minimum of 3 views | 14 | $413 | $23 |
| X-ray of both hips, 2 views | 12 | $385 | $32 |
| X-ray of pelvis, 1-2 views | 17 | $355 | $21 |
2017: 17 services
| Short return visit (20+ min) | 204 | $21,030 | $52 |
| Replacement of knee joint, both sides of knee | 11 | $12,730 | $1,157 |
| Return visit (30+ min) | 81 | $6,879 | $78 |
| New patient visit (30+ min) | 71 | $5,679 | $80 |
| Injection into tendon or ligament | 64 | $3,319 | $36 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,266 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,108 | $105 |
| New patient visit (45+ min) | 17 | $1,876 | $110 |
| X-ray of knee, 3 views | 48 | $1,525 | $26 |
| X-ray of foot, minimum of 3 views | 33 | $1,058 | $21 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $900 | $32 |
| X-ray of knee, 1-2 views | 26 | $753 | $24 |
| X-ray of hip, 2-3 views | 11 | $629 | $33 |
| X-ray of ankle, minimum of 3 views | 16 | $610 | $25 |
| Aspiration and/or injection of fluid from large joint | 11 | $517 | $40 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 73 | $496 | None |
| X-ray of shoulder, minimum of 2 views | 11 | $317 | $20 |
2016: 16 services
| Replacement of knee joint, both sides of knee | 25 | $30,866 | $1,187 |
| Short return visit (20+ min) | 185 | $20,596 | $54 |
| New patient visit (30+ min) | 78 | $6,022 | $77 |
| Return visit (30+ min) | 75 | $5,924 | $75 |
| Injection into tendon or ligament | 52 | $3,329 | $44 |
| New patient visit (45+ min) | 24 | $2,582 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $2,172 | $121 |
| X-ray of foot, minimum of 3 views | 43 | $1,564 | $22 |
| X-ray of knee, 1-2 views | 44 | $1,490 | $25 |
| Application of walking cast covering below knee to toe | 13 | $1,378 | $69 |
| X-ray of knee, 3 views | 37 | $1,127 | $26 |
| Aspiration and/or injection of fluid from large joint | 13 | $804 | $47 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 13 | $734 | $31 |
| X-ray of ankle, minimum of 3 views | 14 | $607 | $23 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 56 | $331 | None |
| X-ray of shoulder, minimum of 2 views | 13 | $321 | $21 |
2015: 19 services
| Replacement of knee joint, both sides of knee | 19 | $21,801 | $991 |
| Short return visit (20+ min) | 185 | $20,073 | $56 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 12 | $7,196 | None |
| Return visit (30+ min) | 77 | $6,632 | $76 |
| New patient visit (30+ min) | 72 | $5,900 | $82 |
| Injection into tendon or ligament | 58 | $3,547 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,860 | $110 |
| New patient visit (45+ min) | 20 | $2,601 | $130 |
| X-ray of foot, minimum of 3 views | 49 | $2,104 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,796 | $62 |
| X-ray of knee, 3 views | 33 | $1,218 | $28 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,014 | $46 |
| X-ray of knee, 1-2 views | 28 | $954 | $25 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 11 | $540 | $32 |
| X-ray of ankle, minimum of 3 views | 11 | $409 | $26 |
| X-ray of shoulder, minimum of 2 views | 15 | $396 | $25 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 64 | $380 | None |
| X-ray of ribs of one side of body, minimum of 2 views | 11 | $325 | $27 |
| X-ray of pelvis, 1-2 views | 13 | $306 | $24 |
2014: 20 services
| Short return visit (20+ min) | 209 | $23,380 | $55 |
| Replacement of knee joint, both sides of knee | 18 | $19,549 | $1,086 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 17 | $12,939 | None |
| Return visit (30+ min) | 90 | $8,217 | $80 |
| New patient visit (30+ min) | 83 | $6,073 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,601 | $100 |
| Injection into tendon or ligament | 65 | $3,857 | $42 |
| New patient visit (45+ min) | 29 | $3,310 | $114 |
| X-ray of foot, minimum of 3 views | 55 | $2,386 | $26 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,066 | $59 |
| X-ray of knee, 3 views | 44 | $1,642 | $29 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,591 | $47 |
| Application of walking cast covering below knee to toe | 12 | $1,484 | $67 |
| X-ray of ankle, minimum of 3 views | 23 | $1,142 | $27 |
| X-ray of knee, 1-2 views | 31 | $1,029 | $26 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 12 | $726 | $32 |
| X-ray of shoulder, minimum of 2 views | 17 | $465 | $24 |
| X-ray of hip on one side of body, 1 view | 13 | $430 | $24 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 67 | $394 | None |
| X-ray of pelvis, 1-2 views | 12 | $281 | $23 |
2013: 22 services
| Short return visit (20+ min) | 234 | $26,324 | $57 |
| Replacement of knee joint, both sides of knee | 17 | $17,407 | $1,024 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 18 | $11,632 | None |
| Return visit (30+ min) | 118 | $9,697 | $76 |
| New patient visit (30+ min) | 103 | $7,868 | $76 |
| Correction of toe joint deformity | 12 | $5,629 | $194 |
| Injection into tendon or ligament | 79 | $4,998 | $44 |
| New patient visit (45+ min) | 38 | $4,833 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,031 | $101 |
| X-ray of foot, minimum of 3 views | 62 | $2,734 | $27 |
| Application of walking cast covering below knee to toe | 18 | $2,052 | $64 |
| X-ray of knee, 3 views | 47 | $1,834 | $32 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,378 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,346 | $56 |
| X-ray of knee, 1-2 views | 35 | $1,074 | $28 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 20 | $1,023 | $30 |
| X-ray of ankle, minimum of 3 views | 27 | $984 | $30 |
| X-ray of ribs of one side of body, minimum of 2 views | 15 | $572 | $36 |
| X-ray of hip on one side of body, 1 view | 11 | $523 | $25 |
| X-ray of pelvis, 1-2 views | 19 | $522 | $26 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 87 | $512 | None |
| X-ray of shoulder, minimum of 2 views | 13 | $390 | $28 |
Drugs they prescribed that Part D paid
$17,558
Pharmacies billed $17,558 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 33% of their Part D prescriptions (591 of 1,788) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
1,766 generic and 22 brand-name prescriptions · $17,558 in drug cost · 117 antibiotic prescriptions to 76 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 276 | $3,284 | $12 |
| Ibuprofen | 235 | $2,609 | $11 |
| Oxycodone-Acetaminophen | 131 | $1,341 | $10 |
| Methylprednisolone | 202 | $1,312 | $6 |
| Celecoxib | 40 | $867 | $22 |
See all 25 drugs
| Hydrocodone-Acetaminophen | 276 | $3,284 | $12 |
| Ibuprofen | 235 | $2,609 | $11 |
| Oxycodone-Acetaminophen | 131 | $1,341 | $10 |
| Methylprednisolone | 202 | $1,312 | $6 |
| Celecoxib | 40 | $867 | $22 |
| Lidocaine | 19 | $761 | $40 |
| Diclofenac | 51 | $659 | $13 |
| Tramadol | 164 | $627 | $4 |
| Meloxicam | 202 | $544 | $3 |
| Gabapentin | 55 | $440 | $8 |
| Amoxicillin-Clavulanate Potass | 48 | $354 | $7 |
| Temazepam | 12 | $230 | $19 |
| Duloxetine | 12 | $223 | $19 |
| Cephalexin | 34 | $196 | $6 |
| Alprazolam | 45 | $154 | $3 |
| Ciprofloxacin | 14 | $92 | $7 |
| Carisoprodol | 26 | $81 | $3 |
| Naproxen | 11 | $77 | $7 |
| Triamcinolone Acetonide | 15 | $75 | $5 |
| Zolpidem | 11 | $62 | $6 |
| Irbesartan | 11 | $43 | $4 |
| Cyclobenzaprine | 12 | $40 | $3 |
| Atorvastatin | 11 | $21 | $2 |
| Tizanidine | 14 | $16 | $1 |
| Lisinopril | 13 | $3 | $0 |
Year by year
| 2024 | 1,788 | 422 | 33% (591) | 1% | $17,558 |
| 2023 | 1,474 | 357 | 35% (515) | None | $20,693 |
| 2022 | 1,572 | 405 | 34% (536) | None | $44,279 |
| 2021 | 1,110 | 326 | 39% (434) | 2% | $30,180 |
| 2020 | 1,030 | 319 | 39% (405) | 2% | $15,826 |
| 2019 | 1,006 | 329 | 45% (452) | 2% | $15,687 |
| 2018 | 942 | 335 | 46% (429) | 1% | $16,569 |
| 2017 | 1,009 | 343 | 48% (486) | 2% | $18,591 |
| 2016 | 898 | 300 | 51% (455) | 2% | $22,076 |
| 2015 | 785 | 276 | 56% (443) | 3% | $20,828 |
| 2014 | 786 | 263 | 53% (415) | 5% | $25,488 |
| 2013 | 712 | 249 | 50% (359) | 5% | $15,541 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Ibuprofen | 184 | $2,823 | $15 |
| Hydrocodone-Acetaminophen | 220 | $2,816 | $13 |
| Oxycodone-Acetaminophen | 164 | $1,998 | $12 |
| Duloxetine | 12 | $1,957 | $163 |
| Diclofenac | 51 | $1,659 | $33 |
| Celecoxib | 21 | $1,531 | $73 |
| Methylprednisolone | 128 | $1,083 | $8 |
| Meloxicam | 201 | $959 | $5 |
| Tramadol | 113 | $530 | $5 |
| Gabapentin | 40 | $499 | $12 |
| Cephalexin | 30 | $375 | $13 |
| Baclofen | 12 | $251 | $21 |
| Amoxicillin-Clavulanate Potass | 19 | $236 | $12 |
| Irbesartan | 12 | $226 | $19 |
| Atorvastatin | 11 | $207 | $19 |
| Lisinopril | 11 | $207 | $19 |
| Methocarbamol | 14 | $207 | $15 |
| Temazepam | 15 | $203 | $14 |
| Trazodone | 13 | $178 | $14 |
| Eszopiclone | 13 | $168 | $13 |
| Indomethacin | 12 | $146 | $12 |
| Zolpidem | 19 | $105 | $6 |
| Diazepam | 13 | $85 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $80 | $7 |
| Alprazolam | 21 | $34 | $2 |
2022: 17 drugs
| Victoza 3-Pak | 11 | $12,382 | $1,126 |
| Ibuprofen | 201 | $4,214 | $21 |
| Duloxetine | 24 | $3,225 | $134 |
| Hydrocodone-Acetaminophen | 238 | $2,586 | $11 |
| Oxycodone-Acetaminophen | 182 | $2,467 | $14 |
| Celecoxib | 34 | $2,039 | $60 |
| Diclofenac | 53 | $2,017 | $38 |
| Methylprednisolone | 154 | $1,516 | $10 |
| Meloxicam | 232 | $1,471 | $6 |
| Gabapentin | 49 | $962 | $20 |
| Cephalexin | 28 | $410 | $15 |
| Tramadol | 104 | $391 | $4 |
| Amoxicillin-Clavulanate Potass | 20 | $373 | $19 |
| Methocarbamol | 14 | $249 | $18 |
| Alprazolam | 26 | $163 | $6 |
| Diazepam | 16 | $127 | $8 |
| Zolpidem | 14 | $38 | $3 |
2021: 13 drugs
| Ibuprofen | 142 | $2,128 | $15 |
| Oxycodone-Acetaminophen | 154 | $1,989 | $13 |
| Hydrocodone-Acetaminophen | 189 | $1,921 | $10 |
| Duloxetine | 21 | $1,336 | $64 |
| Gabapentin | 46 | $864 | $19 |
| Diclofenac | 41 | $849 | $21 |
| Meloxicam | 159 | $815 | $5 |
| Celecoxib | 12 | $633 | $53 |
| Methylprednisolone | 63 | $613 | $10 |
| Tramadol | 77 | $370 | $5 |
| Amoxicillin-Clavulanate Potass | 26 | $360 | $14 |
| Ciprofloxacin | 13 | $110 | $8 |
| Alprazolam | 17 | $91 | $5 |
2020: 14 drugs
| Oxycodone-Acetaminophen | 169 | $2,410 | $14 |
| Ibuprofen | 140 | $1,996 | $14 |
| Duloxetine | 32 | $1,405 | $44 |
| Hydrocodone-Acetaminophen | 131 | $1,367 | $10 |
| Diclofenac | 31 | $1,261 | $41 |
| Meloxicam | 168 | $832 | $5 |
| Pregabalin | 22 | $818 | $37 |
| Celecoxib | 18 | $815 | $45 |
| Methylprednisolone | 59 | $605 | $10 |
| Tramadol | 90 | $543 | $6 |
| Amoxicillin-Clavulanate Potass | 22 | $305 | $14 |
| Gabapentin | 19 | $198 | $10 |
| Potassium Chloride | 14 | $131 | $9 |
| Cephalexin | 12 | $99 | $8 |
2019: 13 drugs
| Oxycodone-Acetaminophen | 224 | $3,787 | $17 |
| Diclofenac | 39 | $1,974 | $51 |
| Duloxetine | 20 | $1,373 | $69 |
| Hydrocodone-Acetaminophen | 121 | $1,358 | $11 |
| Ibuprofen | 78 | $1,271 | $16 |
| Celecoxib | 19 | $961 | $51 |
| Meloxicam | 135 | $791 | $6 |
| Tramadol | 95 | $698 | $7 |
| Methylprednisolone | 54 | $669 | $12 |
| Gabapentin | 36 | $469 | $13 |
| Ibu | 32 | $460 | $14 |
| Amoxicillin-Clavulanate Potass | 20 | $239 | $12 |
| Cyclobenzaprine | 13 | $126 | $10 |
2018: 14 drugs
| Oxycodone-Acetaminophen | 190 | $4,109 | $22 |
| Hydrocodone-Acetaminophen | 134 | $1,713 | $13 |
| Lidocaine | 11 | $1,678 | $153 |
| Celecoxib | 11 | $1,613 | $147 |
| Duloxetine | 11 | $1,063 | $97 |
| Meloxicam | 165 | $758 | $5 |
| Ibu | 54 | $710 | $13 |
| Methylprednisolone | 58 | $682 | $12 |
| Diclofenac | 21 | $682 | $32 |
| Tramadol | 87 | $599 | $7 |
| Gabapentin | 37 | $517 | $14 |
| Ibuprofen | 26 | $452 | $17 |
| Amoxicillin-Clavulanate Potass | 23 | $215 | $9 |
| Cephalexin | 15 | $189 | $13 |
2017: 15 drugs
| Oxycodone-Acetaminophen | 223 | $4,878 | $22 |
| Hydrocodone-Acetaminophen | 163 | $2,015 | $12 |
| Celecoxib | 14 | $1,109 | $79 |
| Gabapentin | 65 | $796 | $12 |
| Methylprednisolone | 55 | $708 | $13 |
| Diclofenac | 26 | $543 | $21 |
| Tramadol | 79 | $469 | $6 |
| Meloxicam | 100 | $422 | $4 |
| Ibu | 31 | $401 | $13 |
| Ibuprofen | 27 | $376 | $14 |
| Amoxicillin-Clavulanate Potass | 21 | $256 | $12 |
| Diazepam | 28 | $240 | $9 |
| Baclofen | 14 | $227 | $16 |
| Cephalexin | 24 | $212 | $9 |
| Hydromorphone | 13 | $109 | $8 |
2016: 14 drugs
| Oxycodone-Acetaminophen | 213 | $6,319 | $30 |
| Hydrocodone-Acetaminophen | 172 | $3,365 | $20 |
| Celecoxib | 17 | $1,781 | $105 |
| Gabapentin | 68 | $903 | $13 |
| Methylprednisolone | 53 | $860 | $16 |
| Diclofenac | 37 | $774 | $21 |
| Ibuprofen | 37 | $541 | $15 |
| Tramadol | 60 | $467 | $8 |
| Amoxicillin-Clavulanate Potass | 22 | $331 | $15 |
| Zolpidem | 17 | $243 | $14 |
| Cephalexin | 27 | $234 | $9 |
| Diazepam | 17 | $210 | $12 |
| Meloxicam | 30 | $152 | $5 |
| Baclofen | 11 | $109 | $10 |
2015: 14 drugs
| Oxycodone-Acetaminophen | 181 | $4,757 | $26 |
| Hydrocodone-Acetaminophen | 171 | $3,527 | $21 |
| Methylprednisolone | 39 | $785 | $20 |
| Tramadol | 75 | $486 | $6 |
| Diclofenac | 26 | $372 | $14 |
| Ibuprofen | 37 | $359 | $10 |
| Gabapentin | 44 | $348 | $8 |
| Zolpidem | 13 | $192 | $15 |
| Amoxicillin-Clavulanate Potass | 13 | $181 | $14 |
| Meloxicam | 29 | $181 | $6 |
| Methocarbamol | 18 | $165 | $9 |
| Cephalexin | 21 | $158 | $8 |
| Diazepam | 18 | $157 | $9 |
| Ciprofloxacin | 11 | $129 | $12 |
2014: 16 drugs
| Oxycodone-Acetaminophen | 149 | $3,415 | $23 |
| Hydrocodone-Acetaminophen | 182 | $3,325 | $18 |
| Methylprednisolone | 53 | $973 | $18 |
| Ibuprofen | 45 | $555 | $12 |
| Endocet | 15 | $537 | $36 |
| Tramadol | 55 | $444 | $8 |
| Meloxicam | 42 | $285 | $7 |
| Gabapentin | 33 | $275 | $8 |
| Amox Tr-Potassium Clavulanate | 16 | $213 | $13 |
| Diclofenac | 11 | $211 | $19 |
| Cephalexin | 20 | $170 | $9 |
| Zolpidem | 19 | $158 | $8 |
| Methocarbamol | 11 | $119 | $11 |
| Diazepam | 14 | $115 | $8 |
| Ciprofloxacin | 12 | $107 | $9 |
| Sulfamethoxazole-Trimethoprim | 11 | $72 | $7 |
2013: 15 drugs
| Hydrocodone-Acetaminophen | 189 | $2,651 | $14 |
| Methylprednisolone | 54 | $1,248 | $23 |
| Oxycodone-Acetaminophen | 78 | $763 | $10 |
| Gabapentin | 40 | $505 | $13 |
| Ibuprofen | 45 | $485 | $11 |
| Tramadol | 43 | $483 | $11 |
| Roxicet | 29 | $316 | $11 |
| Naproxen | 27 | $238 | $9 |
| Cephalexin | 28 | $233 | $8 |
| Cyclobenzaprine | 12 | $212 | $18 |
| Zolpidem | 20 | $180 | $9 |
| Meloxicam | 23 | $132 | $6 |
| Diazepam | 16 | $122 | $8 |
| Levothyroxine | 11 | $91 | $8 |
| Ciprofloxacin | 12 | $89 | $7 |
Money from drug and device companies
$772 in 2025
| 2025 | 4 | 11 | None | $772 |
| 2024 | 3 | 4 | None | $322 |
| 2023 | 3 | 5 | None | $120 |
| 2022 | 2 | 4 | None | $77 |
| 2021 | 2 | 2 | None | $189 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 4 | 4 | None | $166 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $532 | 5 payments
|
| Smith+Nephew | Legion | $106 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $74 | 3 payments
|
| Zimmer Biomet Holdings | Gel-One Cross-Linked Hyaluronate | $61 | 2 payments
|
See all 11 published payments
| Zimmer Biomet Holdings | Meals · 2025-11-13 | Avenir | $24 |
| Vertex Pharmaceuticals | Meals · 2025-10-29 | Journavx | $21 |
| Stryker | Meals · 2025-10-21 | Mako | $127 |
| Stryker | Meals · 2025-08-16 | Mako | $166 |
| Vertex Pharmaceuticals | Meals · 2025-08-06 | Journavx | $21 |
| Stryker | Meals · 2025-07-17 | Mako | $40 |
| Vertex Pharmaceuticals | Meals · 2025-06-12 | Journavx | $31 |
| Zimmer Biomet Holdings | Meals · 2025-04-23 | Gel-One Cross-Linked Hyaluronate | $37 |
| Smith+Nephew | Meals · 2025-02-19 | Legion | $106 |
| Stryker | Meals · 2025-02-05 | Mako | $55 |
| Stryker | Meals · 2025-01-30 | Mako | $144 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $322
| Smith+Nephew | Legion | $163 | 2 payments
|
| Zimmer Biomet Holdings | None | $142 | 1 payment
|
| Ethicon US | Echelon Flex | $17 | 1 payment
|
2023: $120
| Zimmer Biomet Holdings | Samples Biologics | $55 | 2 payments
|
| Kowa Pharmaceuticals America | Seglentis | $45 | 2 payments
|
| Saxum Surgical | None | $20 | 1 payment
|
2022: $77
| Globus Medical | Anthem | $63 | 3 payments
|
| Paragon 28 | Ex-Fix | $13 | 1 payment
|
2021: $189
| Next Science | Surgx | $156 | 1 payment
|
| Zimmer Biomet Holdings | Rosa-Knee | $33 | 1 payment
|
2020: $18
| Ethicon US | Stratafix | $18 | 1 payment
|
2019: $166
| Zimmer Biomet Holdings | Hips Product Portfolio | $119 | 1 payment
|
| Terumo BCT | Bone Marrow Aspirate Concentrate System | $20 | 1 payment
|
| Sanofi-Aventis U.S. | Synvisc-One | $16 | 1 payment
|
| Ethicon US | Mega Soft | $12 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 19.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1477571834
- Licence
- CA G43156California G43156: Current · expires 2028-02-29
- Trained
- University of Southern California Keck School of Medicine, 1979 · 47 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G431560
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 931 Buena Vista St, Ste 505, Duarte, CA, 91010
- NPI first listed
- 2006-07-17
- NPI last updated
- 2010-01-05
This is when the NPI record was last certified, not a medical board exam.